Merck Receives Breakthrough Therapy Designation from U.S. FDA for KEYTRUDA® in Classical Hodgkin...
Merck known as MSD outside the United States and Canada, today announced that the U.S....
Bayer to present latest preclinical data on oncology compounds in 107th Annual Meeting of...
Bayer will present latest preclinical data on oncology compounds, which are currently in preclinical or...
Kanuma receives marketing approval in Japan for Treatment of Patients with Lysosomal Acid Lipase...
Alexion Pharmaceuticals, Inc announced that Japan’s Ministry of Health, Labour and Welfare has approved Kanuma...
Phase 3 Study Findings Demonstrate Treatment With Baricitinib Results In Significant Improvements For Patients...
Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) announced that detailed results...
Proteostasis Therapeutics, Inc. Presents New Data Demonstrating Potential for Genotype-Agnostic and Combination Therapies for...
Proteostasis Therapeutics, Inc. (NASDAQ: PTI), a biopharmaceutical company developing small molecule therapeutics to treat diseases...
ASLAN Pharmaceuticals named Asian Biotech of the year
ASLAN Pharmaceuticals (ASLAN), a biotech company focused on the development of immunotherapies and targeted agents...
FDA Grants Genentech’s Cancer Immunotherapy Atezolizumab Priority Review for Advanced Bladder Cancer
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that...
Quintiles and the American College of Surgeons Announce Agreement to Develop Clinical Registry of...
Quintiles and the American College of Surgeons (ACS) today announced a six-year strategic services agreement...
Amgen Wins Patent Case On Repatha
Amgen announced that a Delaware jury delivered a verdict in Amgen's favor in a trial...
Biocon Inks Co-Development & Commercialization Agreement with Lab PiSA for rh- Insulin in USA
Biocon Ltd. (BSE code: 532523, NSE: BIOCON) Asia's premier biopharmaceuticals company, announced today that its...
